Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-02-10
1997-03-04
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514255, 514318, 514321, 514326, 514340, 514408, 514422, 514428, 544336, 546193, 546196, 546197, 546213, 5462837, 5462841, 548567, 548568, 548566, A61K 31445, A61K 3140, C07D40506, C07D20708
Patent
active
056079508
ABSTRACT:
The invetion is a method of treating irritable bowel syndrome with a compound selected from the formula ##STR1## wherein R, R.sup.1, m, n p are as defined in the specification, or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 4810713 (1989-03-01), Yanni et al.
patent: 4950674 (1990-08-01), Yanni et al.
patent: 5070087 (1991-12-01), Teng
patent: 5096890 (1992-03-01), Cross
patent: 5233053 (1993-08-01), Cross
D. A. Walsh et al.: "Synthesis and anti-allergy activity of 4-(diarylhydroxy-methyl)-1-[3-(acryloxy)propylipiperidines] and structurally related compounds", Journal of Medicinal Chemistry, vol. 32, No. 1, Jan. 1989, American Chemical Society.
Alker David
Cross Peter E.
MacKenzie Alexander R.
Butterfield Garth C.
Chang Ceila
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Muscarinic receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscarinic receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarinic receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2146174